Role that each NKG2A immunoreceptor tyrosine-based inhibitory motif plays in mediating the human CD94/NKG2A inhibitory signal

Journal of Immunology

Volumn 169, Issue 4, 2002, Pages 1948-1958

  Kabat, Juraj ^a   Borrego, Francisco ^a   Brooks, Andrew ^a   Coligan, John E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; FC RECEPTOR; MUTANT PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2A; PERVANADATE; RECEPTOR PROTEIN; SEROTONIN; TYROSINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; IMMUNOCHEMISTRY; LEUKEMIA CELL LINE; MAST CELL LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SEROTONIN RELEASE; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; WILD TYPE;

EID: 0037103239     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.4.1948     Document Type: Article

References (53)

1. Early signaling via inhibitory and activating NK receptors
2. Regulation of immune responses through inhibitory receptors
3. Natural killer cells, viruses and cancer
4. Human natural killer cell activating receptors
5. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
6. NK cell activation: Distinct stimulatory pathways counterbalancing inhibitory signals
7. Turning on natural killer cells
8. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells
9. HLA-E is the ligand for the natural killer cell CD94/NKG2 receptors
10. HLA class I recognition by killer cell Ig-like receptors
11. Signaling pathways engaged by NK cell receptors: Double concerto for activating receptors, inhibitory receptors and NK cells
12. The biology of natural killer cells in cancer, infection, and pregnancy
13. Immune inhibitory receptors
14. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors
15. Differential association of phosphatases with hematopoietic co-receptors bearing immunoreceptor tyrosine-based inhibition motifs
16. A novel phosphotyrosine motif with a critical amino acid at position -2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1
17. Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by FcγRIIB
18. An immunoreceptor tyrosine-based inhibitory motif, with serine at site Y-2, binds SH2-domain-containing phosphatases
19. PILRα, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRβ
20. The proteintyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation: Evidence for a mechanistic link between PECAM-1-and integrin-mediated cellular signaling
21. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): Inhibition of TCR-mediated signal transduction
22. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling
23. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal
24. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1
25. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors
26. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C
27. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: Association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases
28. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class lb molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: Evidence for receptor function in heterologous transfectants
29. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C
30. Tyrosine phosphorylation in T cells is regulated by phosphatase activity: Studies with phenylarsine oxide
31. Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs
32. Isolation and characterization of NK cell or NK/T cell-specific cDNA clones
33. b
34. b inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes
35. Two genes in the rat homologous to human NKG2
36. Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains
37. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation
38. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation
39. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling
40. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-γ, signaling complex in human natural killer (NK) cells
41. SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors
42. The high-affinity 1gE receptor (FcεRI): From physiology to pathology
43. Genetic analysis of protein tyrosine phosphatases
44. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2
45. Crystal structure of the tyrosine phosphatase SHP-2
46. Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatases
47. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2
48. Tandem SH2 domains confer high specificity in tyrosine kinase signaling
49. Activation of protein-tyrosine phosphatase SH-PTP2 by a tyrosine-based activation motif of a novel brain molecule
50. Characterization of protein tyrosine phosphatase SH-PTP2: Study of phosphopeptide substrates and possible regulatory role of SH2 domains
51. Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1
52. Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2
53. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B